Cell No. : Cell Name HPS3933 :  update : 2025/05/08
Comment			Currently not ready. Disease specific iPS cell line derived from a patient : Retinitis pigmentosa.
Comment from the depositor			Disease-specific iPS cell line. Established from monocyte of a retinitis pigmentosa patient using episomal plasmid encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1.
Terms and conditions
Remarks
Order Form
			Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
	Basic information	Expected time	Upon a request we will start preparation. Contact us: cellips.brc@riken.jp
Reference information		Reference	1
		User's Publication	0

Top

Reference

22183  Otsuka Y, Imamura K, Oishi A, Asakawa K, Kondo T, Nakai R, Suga M, Inoue I, Sagara Y, Tsukita K, Teranaka K, Nishimura Y, Watanabe A, Umeyama K, Okushima N, Mitani K, Nagashima H, Kawakami K, Muguruma K, Tsujikawa A, Inoue H.  Phototoxicity avoidance is a potential therapeutic approach for retinal dystrophy caused by EYS dysfunction  JCI Insight  2024  9(8):e174179  PubMed ID: 38646933   DOI: 10.1172/jci.insight.174179

Top

User's Publication